TScan Therapeutics

TScan Therapeutics is a fully integrated clinical-stage biotechnology company developing T cell receptor-engineered T cell (TCR-T) therapies for cancer. Its proprietary target-discovery platform supports development of therapies that harness the human immune system, including candidates for hematologic malignancies and solid tumors. The company also uses its technology to study autoimmune disorders and discover novel autoantigens that could enable targeted treatments for patients with serious diseases.